Epic Angels, a prominent female-focused investment collective, has recently announced its participation in a funding round for Colombian healthcare startup, Salva Health. This investment is set to propel the growth of Salva Health and support the development of its flagship product, the Julieta device. The undisclosed funding amount will enable Salva Health to further enhance its operations and expand its reach within the healthcare industry. Salva Health, led by CEO Valentina Agudelo, is known for its innovative healthcare solutions aimed at improving patient care and outcomes. The Julieta device, a key focus of the startup, offers a unique approach to addressing healthcare challenges in Colombia and beyond. With Epic Angels' backing, Salva Health is poised to accelerate its mission of leveraging technology to make a positive impact on healthcare delivery in the region. The investment from Epic Angels not only provides vital financial support but also signifies a strong belief in Salva Health's vision and capabilities. This strategic partnership is expected to drive innovation within the healthcare sector and position Salva Health as a key player in the market. As the startup continues to gain traction and expand its offerings, the collaboration with Epic Angels is anticipated to fuel its growth trajectory and solidify its position as a leading healthcare technology company in Latin America. With this recent funding injection, Salva Health is well-positioned to strengthen its market presence and advance its ambitious goals in revolutionizing healthcare services. Epic Angels' vote of confidence in the startup underscores the potential impact of Salva Health's innovations in the healthcare landscape. As both entities join forces, the future looks promising for Salva Health and its mission to drive positive change through cutting-edge healthcare solutions. ---
Epic Angels Funds Colombia's Salva Health and its Julieta Device
Global female investment collective Epic Angels recently invested in Colombia's Salva Health, supporting their innovative Julieta device.